–Early access researchers will present data at the annual meeting of the American Association for Cancer Research in Chicago this week– PLEASANTON, CA.—10x Genomics, a company focused on accelerating genomic discovery, today launched the Chromium Single Cell CNV Solution, which is the first scalable and easy-to-use technology for rapid and massively parallel profiling of single cell […]
Expands Illumina’s Oncology Offerings for NextSeq™ 550Dx A Diagnostic Version of the Illumina TruSight™ Oncology 500 Assay Will Measure Potentially Predictive Genomic Biomarkers, Including Tumor Mutation Burden NEW YORK & SAN DIEGO–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE: BMY) and Illumina, Inc. (NASDAQ: ILMN) today announced a collaboration that will utilize Illumina’s next-generation sequencing (NGS) technology to develop and globally […]
Tokyo, Japan – Hitachi High-Technologies Corporation (TSE:8036, Hitachi High-Tech) announced Hitachi High-Tech’ s capital participation in OmniSeq®,Inc. (OmniSeq), which is a molecular diagnostics subsidiary of the Roswell Park Comprehensive Cancer Center, which was the first institution to focus exclusively on cancer research. Hitachi High-Tech has made the field of biotechnology and healthcare its priority. Amid […]
Scientists in North America can now benefit from the high contrast, label-free, live cell imaging provided by Livecyte™, following the appointment of Bulldog Bio as the Phasefocus™ distributor for USA and Canada. This announcement signals the start of an exciting time for Phasefocus, as the company seeks to make headway on its initial achievements and […]
SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) today announced the introduction of the Advanta™ CFTR NGS Library Prep Assay, a highly efficient and scalable next-generation sequencing (NGS) library prep workflow for sequencing of the CFTR (cystic fibrosis transmembrane conductance regulator) gene. Cystic fibrosis (CF) is a complex, multisystem disease that is caused by mutations in the […]
AACR 2018 Annual Meeting includes 40-plus abstracts covering QIAGEN Sample to Insight solutions Germantown, Maryland, and Hilden, Germany, April 12, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today launched two novel liquid biopsy panels to evaluate circulating tumor cells (CTCs) in the growing field of research into molecular mechanisms in prostate and lung […]
Extends Horizon’s biomanufacturing capabilities into vaccine manufacture Research supported by a grant from the Canadian International Development Research Centre, funded by the Bill and Melinda Gates foundation Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Group”), a global leader in the application of gene editing and gene modulation to deliver inspired […]
St. Jude Children’s Research Hospital, in collaboration with Microsoft and DNAnexus, offers extensive next-generation sequencing data and unique analysis tools to accelerate research and cures for life-threatening pediatric diseases St. Jude Children’s Research Hospital today launched St. Jude Cloud, an online data-sharing and collaboration platform that provides researchers access to the world’s largest public repository […]
MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced that the HudsonAlpha Institute for Biotechnology is using the organization’s newest Sequel® Sequencing System to support the goal of dramatically increasing the diagnostic success rate in challenging pediatric clinical cases. Led by faculty investigator Greg Cooper, Ph.D., the institution’s NIH-funded Clinical Sequencing Exploratory Research (CSER) […]
– Expands Illumina’s Oncology Offerings for NextSeq™ 550Dx with a Companion Diagnostic Version of TruSight™ Tumor 170 for Solid Tumors – – Loxo Oncology to Utilize a Companion Diagnostic Version of TruSight Tumor 170 for Larotrectinib (NTRK) and LOXO-292 (RET) – STAMFORD, Conn. and SAN DIEGO — Loxo Oncology (Nasdaq:LOXO) and Illumina, Inc. (Nasdaq:ILMN) today announced […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
